According to FutureWise analysis the market for peripheral arterial disease (pad) is expected to reach US$ 9.07 billion by 2031 at a CAGR of 9.2%.
Peripheral arterial disease (PAD) is a common cardiovascular disorder caused by plaque build-up in the arteries, which causes blood flow to the limbs to be reduced. Diabetes, ageing, and high blood pressure are all connected to peripheral artery disease.
According to the surveys, PAD affects roughly 6.5 million Americans aged 40 and up. PAD affects both men and women, although African Americans are at a higher risk of developing it. The ageing population, which leads to an increase in peripheral artery disease prevalence, as well as an increase in product approvals, are all factors that enhance the chance of developing peripheral arterial disease (PAD).
FutureWise Market Research has instantiated a report that provides an intricate analysis of Peripheral Arterial Disease (PAD) Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Peripheral Arterial Disease (PAD) Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.